Poor Bone healing is one of the many associated health concerns for diabetics, who are known to have a reduced ability to form bone and have poor bone quality, thus influencing bone healing. Since hyperbaric oxygen has been used for a variety of diabetic-related conditions including poor wound healing, researchers in this study decided to observe the bone healing effects of hyperbaric oxygen therapy over a short 7 day duration. The results showed favorable improvements in bone regeneration and these findings were subsequently published in this journal <view study> Read Less

Oxygen plays a central role in many pathological and disease states. This has led to a strong emphasis being placed on hyperbaric oxygen therapy (HBOT) to help determine the role of oxygen within these states; moreover, to help determine if extra oxygen can help to improve the pathophysioloigcal processes going on within these disease states. In this particular study, researchers looked at oxygen's role in detoxification and its use for withdrawal symptoms in a morphine-dependent rat model. Through the evaluation of withdrawal symptom scores, biochemical indices and neurotransmitters, they found that HBOT was able to cause a significant reduction in both withdrawal symptoms and weight loss. Along with these benefits many key pathophysiological markers including dopamine and other neurotransmitter changes, also showed significant improvements. Together, these findings led the researchers to conclude that HBOT can effectively alleviate withdrawal symptoms induced by morphine dependence. Currently, there are many drug and alcohol centers that are using HBOT for a wide variety of uses, one of which is for addiction control. This study gives us a little more insight towards their rationale and potential benefits <view study>   Read Less

Mild or lower pressure hyperbaric oxygen therapy (aka m-HBOT) was able to demonstrate a marked reduction in Parkinson’s Disease (PD) symptoms in just 11 weeks! PD is a common progressive neurodegenerative disease, of which the main neuropathological hallmark is dopaminergic neuronal loss (degeneration or loss of dopamine-producing neuronal cells). When dopamine-producing neurons die, motor functioning is affected and symptoms such as tremor, slowness, stiffness, and balance problems occur. In this 11 week study, m-HBOT at 1.3 ATA (3 hours per day, 3 times per week) was able to protect the dopaminergic neurons from further loss and degeneration. More importantly, researchers observed positive effects in motor function <view study> Read Less

We all know how difficult it can be to multitask, whether it’s at work or in the home environment. For some of us, it comes easily and is almost like a natural instinct, while for the majority of us, this simple exercise is one that takes a lot of effort and becomes a continual and constant struggle to perform. The good news is that a new study has just shown us that we can improve both single task and multitask performance through the use of hyperbaric oxygen therapy (HBOT). “The study's findings indicate that even for healthy individuals, oxygen at normal conditions is a limiting factor for brain activity. The ability to perform cognitive and/or motor tasks as a single or a combined task (multitask) was evaluated at a normal air/oxygen environment and at HBO, a hyperbaric oxygen enriched environment. Increasing oxygenation using a HBO environment significantly enhanced both cognitive and motor performance. Significant improvements were found for both single tasks as well as simultaneous multiple tasks” <view study> Read Less

The Neurobiology of Aging has just published a study supporting the use of hyperbaric oxygen therapy (HBOT) for Alzheimer’s disease (AD). In this study, they demonstrated the positive impact of HBOT on many of the commonly-found underlying pathologies that are observed in the AD brain. A key focus of this study was on HBOT’s ability to basically halt and reverse the neuro-inflammatory disease progression involved in AD <view study> Read Less